Industry Trend Analysis - CEPI Aims To Prevent Future Epidemics - MAR 2017


BMI View : After the Ebola/Zika outbreak s , the Coalition for Epidemic Preparedness Innovations is promoting the development of nove l vaccines for infectious disease that have potential to cause the next epidemic. Many companies are expected to benefit from the increa sed interest in vaccines for the less- known infectious diseases, especially those that already have vaccines in development. The main risk is the virus could mutate and the vaccine developed would be inefficient ; however , this is a risk worth taking with the current financial burden of infectious disease epidemics.

A global coalition to create new vaccines for emerging infectious diseases, designed to help give the world an insurance policy against epidemics, launched on January 18 2017, at the World Economic Forum in Davos, Switzerland. The global coalition is known as the Coalition for Epidemic Preparedness Innovations (CEPI).

With an initial investment of USD460mn from the governments of Germany, Japan and Norway, plus the Bill & Melinda Gates Foundation and the Wellcome Trust, CEPI will seek to 'outsmart' epidemics by developing safe and effective vaccines against known infectious disease threats that could be deployed rapidly to contain outbreaks, before they become global health emergencies.

This article is part of our Western Europe coverage. To access this article subscribe now or sign up for free trial